New American College of Physicians Guidance on Colorectal Cancer Screening: Less Is More
Authors: Michael Bretthauer, Yu-Xiao Yang
Journal: Annals of Internal Medicine (2023)

EditorialsAugust 2023New American College of Physicians Guidance on Colorectal Cancer Screening: Less Is MoreMichael Bretthauer, MD, PhD, Yu-Xiao Yang, MDMichael Bretthauer, MD, PhDClinical Effectiveness Research Group, University of Oslo, Oslo, Norway, Yu-Xiao Yang, MDDepartment of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PennsylvaniaAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M23-1695 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail A wide variety of screening tests are available for colorectal cancer screening, ranging from inexpensive, noninvasive, but frequently repeated fecal testing for occult blood over long-lasting but invasive and burdensome colonoscopy and sigmoidoscopy to new but expensive fecal DNA markers and other emerging tests. Although the various choices and substantial potential for innovation make colorectal cancer screening an exciting field, they also present a challenge for guideline makers who are tasked with providing up-to-date and evidence-based recommendations for clinical practice.In a new guidance statement, the American College of Physicians (ACP) provides an update of its colorectal cancer screening recommendations ...References1. Qaseem A, Harrod CS, Crandall CJ, et al; Clinical Guidelines Committee of the American College of Physicians. Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians (version 2). Ann Intern Med. 2023;176:1092-1100. doi:10.7326/M23-0779 LinkGoogle Scholar2. Davidson KW, Barry MJ, Mangione CM, et al; US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:1965-1977. [PMID: 34003218] doi:10.1001/jama.2021.6238 CrossrefMedlineGoogle Scholar3. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250-281. [PMID: 29846947] doi:10.3322/caac.21457 CrossrefMedlineGoogle Scholar4. Bretthauer M, Kalager M, Weinberg DS. From colorectal cancer screening guidelines to headlines: beware! Ann Intern Med. 2019;170:734. [PMID: 31108525] doi:10.7326/L19-0086 LinkGoogle Scholar5. Coury J, Ramsey K, Gunn R, et al. Source matters: a survey of cost variation for fecal immunochemical tests in primary care. BMC Health Serv Res. 2022;22:204. [PMID: 35168616] doi:10.1186/s12913-022-07576-4 CrossrefMedlineGoogle Scholar6. Geneoscopy. Geneoscopy's noninvasive colorectal cancer screening test demonstrates high sensitivity and specificity in large pivotal clinical trial [Press release]. 10 January 2023. Accessed at www.geneoscopy.com/geneoscopys-noninvasive-colorectal-cancer-screening-test-demonstrates-high-sensitivity-and-specificity-in-large-pivotal-clinical-trial/ on 20 June 2023. Google Scholar7. Neal RD, Johnson P, Clarke CA, et al. Cell-free DNA–based multi-cancer early detection test in an asymptomatic screening population (NHS-Galleri): design of a pragmatic, prospective randomised controlled trial. Cancers (Basel). 2022;14:4818. [PMID: 36230741] doi:10.3390/cancers14194818 CrossrefMedlineGoogle Scholar8. Helsingen LM, Vandvik PO, Jodal HC, et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019;367:l5515. [PMID: 31578196] doi:10.1136/bmj.l5515 CrossrefMedlineGoogle Scholar9. Lauby-Secretan B, Vilahur N, Bianchini F, et al; International Agency for Research on Cancer Handbook Working Group. The IARC perspective on colorectal cancer screening. N Engl J Med. 2018;378:1734-1740. [PMID: 29580179] doi:10.1056/NEJMsr1714643 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Michael Bretthauer, MD, PhD; Yu-Xiao Yang, MDAffiliations: Clinical Effectiveness Research Group, University of Oslo, Oslo, NorwayDepartment of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PennsylvaniaDisclaimer: The authors are editors at Annals of Internal Medicine.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M23-1695.Corresponding Author: Michael Bretthauer, MD, PhD, Clinical Effectiveness Research Group, University of Oslo, Postbox 1089 Blindern, 0318 Oslo, Norway; e-mail, michael.bretthauer@medisin.uio.no.This article was published at Annals.org on 1 August 2023. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoScreening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2) Amir Qaseem , Curtis S. Harrod , Carolyn J. Crandall , and Timothy J. Wilt , for the Clinical Guidelines Committee of the American College of Physicians Metrics August 2023Volume 176, Issue 8Page: 1127-1128KeywordsCancer preventionCancer screeningColonoscopyColorectal cancerColorectal cancer screening ePublished: 1 August 2023 Issue Published: August 2023 Copyright & PermissionsCopyright © 2023 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...